We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Protected Droplets Could Revolutionize Methods of Targeting Medicines to Specific Body Locations

By HospiMedica International staff writers
Posted on 08 Dec 2023

Emulsions are mixtures consisting of droplets suspended in a liquid where they don’t dissolve or mix. More...

A common example is milk, where fat droplets, stabilized by milk proteins, are dispersed in water. In fields like medicine delivery, it's vital not only to preserve the structure of these droplets but also to control their dissolution. This is critical because active ingredients encapsulated within the droplets should be released only after the medicine enters the body. Researchers have now developed a method for creating responsive emulsions that allows for precise control over the dissolution of these droplets. This innovation has the potential to transform how medicines are targeted within the body.

The research, conducted by the University of Gothenburg (Gothenburg, Sweden), focuses on microgels that encase a droplet and protect it until a specific temperature threshold is reached. These microgels form a protective shell around a droplet, which remains intact until the temperature exceeds 32 degrees Celsius. At this point, the microgels contract, leading to the dissolution of the droplet in the surrounding liquid. This temperature-triggered behavior of the droplets, long recognized in scientific studies, has now been explained by the Gothenburg research team. They discovered that the fundamental mechanism behind these stimuli-responsive emulsions is the morphological changes in the stabilizing microgels.

The team found that the dual nature of the microgels, as both particles and polymers, is essential for the stability and responsiveness of the emulsion. The particle aspect contributes to the emulsion's stability, while the polymer aspect allows the microgels to respond to external stimuli, leading to the droplets’ dissolution. Creating temperature-sensitive emulsions requires a balance: minimal particle character for stability and significant polymer character for the prompt and effective dissolution of the droplets. The researchers are now focusing on developing microgel-stabilized emulsions that react to the pH level of the surrounding fluid. This research is particularly significant for pharmaceuticals, where the aim is to concentrate medication delivery to specific diseased areas within the body, minimizing overall body impact.

“Responsive emulsions hold great potential as a precise tool for delivering medicine to specific areas in the body. Although additional research is needed, the future looks promising, and advancements can be expected over the next 10 years,” said Marcel Rey, a researcher in Physics at the University of Gothenburg and lead author of the study.

Related Links:
University of Gothenburg


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.